Jet Lidocaine for Pain Relief During Needle Insertion in a Pediatric Emergency Department

Completed · Not applicable · Has a placebo group

Conditions studied: Pain

In brief

The purpose of this study is to explore to what degree, if any, Jet lidocaine will reduce or alleviate pain, as compared to Jet normal saline, in children undergoing needle insertion in the Pediatric Emergency Department (PED). If effective, Jet lidocaine would afford a novel rapidly acting local anesthesic for children in the PED.

Key facts

Study ID

NCT00681902

Run by

NYU Langone Health

People needed

150

Starts

2007-03-01

Expected to finish

2008-07-01

Last updated by the study team

2009-02-06

Who can join

Age: 5 and older, up to 19. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age 5 - 18 years
• Evaluation and treatment requiring needle insertion in <60 minutes (Patient is not a candidate for EMLA cream)
• Parent or patient consent, and child assent

You may not qualify if…

• Age <5 years or >18 years
• Children eligible for or receiving EMLA cream
• Significant blunt or penetrating trauma requiring rapid evaluation/resuscitation (GCS<15)
• Unstable shock
• Altered sensorium or intoxication
• History of allergy to Lidocaine
• Neurologic deficit involving a lack of sensation in area of insertion
• Developmental delay so as not to understand pain scale

Where it is running

• Bellevue Hospital — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.